人类GABA载体3抑制的分子基础
Ravi Yadav1,2, Gye Won Han1, Cornelius Gati3,4,5
1The Bridge Institute, Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA, USA.
Nature communications
|April 23, 2025
概括
研究人员揭示了SNAP-5114如何非竞争性地抑制玛-氨基黄油酸 (GABA) 载体3 (GAT3). 结构和功能研究为设计用于神经系统疾病的新型GAT3向药物提供了基础.
科学领域:
- 神经科学是一个神经科学.
- 结构生物学 结构生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- γ-氨基黄油酸 (GABA) 运输体 (GATs) 通过从突触裂清除GABA来调节神经传递.
- 一个关键的转运体GAT3,对于突触信号传递至关重要,并与神经系统疾病有关.
- 向GAT3为各种神经和神经退行性疾病提供了治疗潜力.
研究的目的:
- 阐明通过SNAP-5114.4抑制GAT3的结构机制.
- 了解SNAP-5114在GAT3.3中的非竞争性抑制机制.
- 为合理的药物设计提供结构基础,以GAT3为目标.
主要方法:
- 低温电子显微镜 (cryo-EM) 用于确定人类GAT3结构.
- 确定阿波-GAT3和GAT3-SNAP-5114复杂结构.
- 变异发生和放射性体吸收试验以验证功能后果.
主要成果:
- 冷-EM结构显示了GAT3在apo和SNAP-5114结合状态中的向内开放的形状.
- SNAP-5114结合于正基质结合口袋,作为一种非竞争性抑制剂.
- 结构上的差异和SNAP-5114的庞大性质解释了GAT3对GAT1.1的选择性抑制.
结论:
- 这项研究揭示了SNAP-5114在GAT3.3上的非竞争性抑制机制.
- 结构洞察力解释了SNAP-5114对GAT3.3的选择性.
- 这些发现为开发新型GAT3特异性疗法提供了框架.
更多相关视频
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
259
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
259
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K
Glucose Transporters
22.2K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
22.2K
Ligand-gated Ion Channels
12.0K
Ligand-gated ion channels are transmembrane proteins with a channel for ions to pass through and a binding site for a ligand. The channel opens only when a ligand attaches to the binding site.
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
Three Subfamilies of Ligand-gated Ion Channels
Ligand-gated ion channels fall into three subfamilies. The 'Cys-loop' includes the nicotinic acetylcholine receptors, γ-aminobutyric acid (GABA), glycine, and 5-hydroxytryptamine receptors. The second one is the 'Pore-loop' channels that...
12.0K
Enzyme Inhibition
77.4K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
77.4K
G-Protein Gated Ion Channels
4.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
4.5K


